UIH(SH:688271) Sou Hu Cai Jing·2025-10-29 23:56Core Insights - The company reported a total revenue of 8.859 billion yuan and a net profit attributable to shareholders of 1.12 billion yuan for Q3 2025 [1] - The operating cash flow showed a net inflow of 107 million yuan [1] Financial Metrics - The latest debt-to-asset ratio is 30.08%, ranking 77th among disclosed peers, with an increase of 2.56 percentage points from the previous quarter and 3.98 percentage points from the same period last year [3] - The latest gross profit margin is 47.02%, ranking 66th among disclosed peers, with a decrease of 0.91 percentage points from the previous quarter and 0.50 percentage points from the same period last year [3] - The return on equity (ROE) stands at 5.38% [3] - The diluted earnings per share (EPS) is 1.36 yuan [3] - The total asset turnover ratio is 0.31 times, and the inventory turnover ratio is 0.80 times, ranking 85th among disclosed peers [3] Shareholder Information - The number of shareholders is 32,400, with the top ten shareholders holding a total of 503 million shares, accounting for 61.04% of the total share capital [3] - The top shareholders include: 1. 联影医疗技术集团有限公司 - 20.3% 2. 上海联和投资有限公司 - 16.3% 3. 上海影升投资合伙企业(有限合伙) - 7.30% 4. 上海易端投资有限公司 - 3.05% 5. 上海中科道富投资合伙企业(有限合伙) - 2.95% 6. 严全良 - 2.39% 7. 香港中央结算有限公司 - 2.31% 8. 中国工商银行股份有限公司 - 2.17% 9. 招商银行股份有限公司 - 2.12% 10. 上海北元投资合伙企业(有限合伙) - 2.05% [3]